<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4316</id>
  <title>T3D4262</title>
  <common-name>3-Hydroxymethylglutaric acid</common-name>
  <description>3-Hydroxymethylglutaric acid is a metabolite that accumulates in the urine of patients affected by 3-Hydroxy-3-methylglutaric aciduria, a rare inborn error of metabolism (OMIM 246450). 3-Hydroxy-3-methylglutaric aciduria is caused by reduced enzyme activity of the intramitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase (EC 4.1.3.4), the enzyme that catalyzes the final step of leucine degradation and plays a key role in ketone body formation. The profile of urinary organic acids is different from that of the other identified defects of leucine degradation--maple syrup urine disease (OMIM 248600), isovaleric acidemia (OMIM 243500), and methylcrotonylglycinemia (OMIM 210200). Clinical manifestations include hepatomegaly, lethargy or coma and apnoea. Biochemically there is a characteristic absence of ketosis with hypoglycemia, acidosis, hipertransaminasemia and variable hyperammoniemia. The urinary organic acid profile includes elevated concentrations of 3-hydroxy-3-isovaleric, 3-hydroxy-3-methylglutaric, 3-methylglutaconic and 3-methylglutaric acids.  (A3352, A3353, A3354).</description>
  <cas>503-49-1</cas>
  <pubchem-id>1662</pubchem-id>
  <chemical-formula>C6H10O5</chemical-formula>
  <weight>162.14</weight>
  <appearance>White powder.</appearance>
  <melting-point>105°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects>Chronically high levels of 3-hydroxymethylglutaric acid are associated with the inborn error of metabolism: 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency.</health-effects>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:09:33Z</created-at>
  <updated-at type="dateTime">2026-05-14T18:07:55Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>3-Hydroxy-3-methylglutaric acid</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C03761</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>16831</chebi-id>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB04377</drugbank-id>
  <pdb-id>MAH</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC(O)(CC(O)=O)CC(O)=O</moldb-smiles>
  <moldb-formula>C6H10O5</moldb-formula>
  <moldb-inchi>InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)</moldb-inchi>
  <moldb-inchikey>NPOAOTPXWNWTSH-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">162.1406</moldb-average-mass>
  <moldb-mono-mass type="decimal">162.05282343</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>-0.75</logp>
  <hmdb-id>HMDB00355</hmdb-id>
  <chembl-id>CHEMBL50444</chembl-id>
  <chemspider-id>1600</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Luigi Turbanti, Giorgio Garzelli, &amp;#8220;Process for preparation of 3-hydroxy-3-methyl-glutaric acid.&amp;#8221; U.S. Patent US4966993, issued October, 1985.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003222</chemdb-id>
  <dsstox-id>DTXSID90198304</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-hydroxy-3-methylpentanedioic acid</iupac>
  <moldb-polar-surface-area>94.83000000000001</moldb-polar-surface-area>
  <moldb-refractivity>34.1377</moldb-refractivity>
  <moldb-polarizability>14.545141112043254</moldb-polarizability>
  <moldb-rotatable-bond-count>4</moldb-rotatable-bond-count>
  <moldb-acceptor-count>5</moldb-acceptor-count>
  <moldb-donor-count>3</moldb-donor-count>
  <moldb-pka-strongest-acidic>3.6777896096277964</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-3.0082279564358467</moldb-pka-strongest-basic>
  <moldb-physiological-charge>-2</moldb-physiological-charge>
  <moldb-number-of-rings>0</moldb-number-of-rings>
  <moldb-alogps-logp>-0.88</moldb-alogps-logp>
  <moldb-alogps-logs>0.23</moldb-alogps-logs>
  <moldb-alogps-solubility>2.75e+02 g/l</moldb-alogps-solubility>
</compound>
